February 16,2006
Senator Grassley's Statement for the Record regarding FDA's Approval Process
Please see the following two documents attached as related files:
(1) Grassley Statement from the Feb. 16 Congressional Record
(2) Report of the Committee Staff Review of the FDA’s Approval Process for the Vagus Nerve Stimulation Therapy System for Treatment-Resistant Depression
Next Article Previous Article
Recent News
- Crapo Announces Finance Committee Staff Updates
- Crapo and Wyden Report Legislative Text of Taxpayer Assistance and Service Act
- Crapo Statement at Hearing on Nominees for HHS, IRS and the U.S. Tax Court
- Crapo Announces Nominations Hearing for HHS, IRS Chief Counsel and Tax Court
- Crapo, Wyden Applaud Extension of Africa and Haiti Trade Programs